Predicting Progression of DCIS to Invasive Cancer
Dr Ettienne Myburgh, Panorama Centre for Surgical Oncology (www.pacso.co.za) explains our current understanding of biology of DCIS and how to guide treatment for patients. Part of the Cape Town Breast Cancer forum talks Feb 2023 0:47 Introduction 5:03 Why treat DCIS 5:52 Clinical Pathological Predictors 8:26 Van Nuys Prognostic Index 9:22 Nomogram to predict recurrence 9:55 Traditional view of how cancer develops 10:34 New models of understanding about progression to invasive cancer 12:25 Genetic evaluation of DCIS and invasive cancer 15:21 Spesific genetic changes 16:03 Importance of germline testing 17:04 Molecular Testing - MammaPrint or OncotypeDx 20:43 Micro-environment 24:15 Clinical decision making in DCIS 26:00 Prospective Analysis of VNPI 28:45 Online Nomogram for DCIS by MSK 29:12 Final Thoughts Corrections: 25:16 Please note Age in col 1 should be over 60

Breast Cancer: Ductal Carcinoma in Situ (DCIS) EXPLAINED

After Treatment: Why Breast Cancer Still Comes Back

Ductal Carcinoma in Situ: An overview

Breast Cancer: MUST know details (ER, PR, HER2, Ki67, etc)

Stage 0 Breast Cancer: Hidden Risks & Real Answers

Breast Cancer | Clinical Medicine

DCIS - What I Wish I'd Known (and took six oncologists over two years to find out!)

Vicki Wolf survived Ductal Carcinoma In Situ and Invasive Ductal Carcinoma-BRCA2 genetic mutation

Is DCIS Really Dangerous?

The Role of Radiation and What to Expect | 2024 Ductal Carcinoma In Situ Patient Forum

Radiation Therapy | 2023 Ductal Carcinoma In Situ Patient Forum

Lobular Breast Cancer Uncovered: Expert Insights With Dr. Liz O'riordan

Should I Take Tamoxifen? ( 5 Things Breast Cancer Survivors Are Not Told )

Understanding Your Pathology Report | 2024 Ductal Carcinoma In Situ Patient Forum

What is DCIS and What Happens if We Don't Treat It? - with Dr Tasha

Use These 5 Food Hacks To Heal The Body & STARVE CANCER I Dr. William Li

A New Study on DCIS

Predictors of Recurrence after a DCIS Diagnosis

Gigi's Story: Stage 2 Invasive Ductal Carcinoma Breast Cancer at 36

